News
One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback